COMMUNIQUÉS West-GlobeNewswire

Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
21/07/2026
Lonza grants Engitix target-specific license for GlycoConnect ® , HydraSpace ® and SYNtecan E™ linker-payload technologies for ADC development Collaboration enables innovative treatments by combining Lonza’s validated [...]
Vivex Biologics Launches VIA Linx™, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advanced Wound Care Solutions
21/07/2026
New molecular medical device joins Vivex's growing suite of allograft and advanced wound care technologies MIAMI, July 21, 2026 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative [...]
Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time
21/07/2026
GERMANTOWN, Md., July 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today [...]
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care
21/07/2026
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announced ASC Solutions: an expanded enterprise strategy for ambulatory surgery centers (ASCs) that takes a customer-centric approach to [...]
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
21/07/2026
Aggregate cash dividend of $17.3 million, or approximately $0.40242 per share NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of [...]
Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
21/07/2026
WEST CHESTER, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological [...]
Vaxart to Participate in BTIG Biotechnology Conference 2026
21/07/2026
SOUTH SAN FRANCISCO, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery [...]
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
21/07/2026
BOSTON, July 21, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
21/07/2026
Capital-efficient strategy focuses on differentiated therapies for cardiac pre- and post-operative critical care and orphan cardiovascular conditions Company is exploring development, licensing, and commercialization [...]
SkinHealth Systems to Report Second Quarter 2026 Financial Results on August 6, 2026
21/07/2026
LONG BEACH, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced it will report second quarter [...]
The National Upper Cervical Chiropractic Association Celebrates 60 Years of Restoring Balance from the Top Down, Creating Optimal Function and Health
21/07/2026
SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- A legacy of longevity. This year, the National Upper Cervical Chiropractic Association (NUCCA) celebrates six decades of advancing education and professional standards [...]
Three Peat: USOSM Recognized as One of the Region’s Fastest Growing Companies by Dallas Business Journal
21/07/2026
IRVING, Texas, July 21, 2026 (GLOBE NEWSWIRE) -- For the third year in a row, Irving’s U.S. Oral Surgery Management ( USOSM ) has secured a spot on the Dallas Business Journal’s list of the region’s fastest growing [...]
Choosing a Shaker Bottle for Thick Pre-Workout Powders: What Actually Prevents Clumping
21/07/2026
PROMIXX set out to fix what defined the manual shaker category, replacing the wire mixing ball with the Snap-Fit Agitator: a lid-locked mixing grid Cardiff, July 21, 2026 (GLOBE NEWSWIRE) -- The Snap-Fit Agitator is an [...]
Myriad Genetics Launches FirstGene® Multiple Prenatal Screen
21/07/2026
The only lab test to run four prenatal genetic screens simultaneously as early as eight weeks gestation SALT LAKE CITY, July 21, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular [...]
SK pharmteco and Genethon Showcase French Manufacturing Strength Behind Pivotal DMD Gene Therapy Program
21/07/2026
Ongoing support for GNT-0004 highlights the capability, readiness, and continued momentum of SK pharmteco’s viral vector operations in France as part of its global network RANCHO CORDOVA, Calif., July 21, 2026 (GLOBE [...]
Nelipak Releases 2025 Sustainability Report
21/07/2026
Highlights achievements aligned to sustainability vision to “help healthcare be sustainable.” CRANSTON, R.I., July 21, 2026 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak ® ”), a leading global provider of [...]
IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer
21/07/2026
Preliminary data reinforces IMNN-001 immunotherapy’s potential for success in the rapidly recruiting Phase 3 OVATION 3 clinical trial Lower rate of minimal residual disease (MRD) Higher ctDNA clearance with IMNN-001 vs [...]
OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
21/07/2026
LONDON and NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Revagenix Expands Executive Team, Names Peter Smith, Ph.D., Chief Scientific Officer as Lead Program Enters the Clinic
21/07/2026
Rev-56 scientific leader promoted to CSO to advance Revagenix’s scientific strategy in non-cystic fibrosis bronchiectasis and other serious chronic diseases SAN FRANCISCO, July 21, 2026 (GLOBE NEWSWIRE) -- Revagenix, [...]

Pages